Back to 
Two Sigma Investments, LP
Two Sigma Investments, LP
VVOS
2 quarters
Position history for Two Sigma Investments, LP's holdings in Vivos Therapeutics, Inc.
No. Two Sigma exited its VVOS (Vivos Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 20,482 shares worth $53,458. Two Sigma first reported VVOS in Q3 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$53,458
Total Shares Change
-20,482
Quarter-by-Quarter History
Other major holders of VVOS: Schonfeld Strategic Advisors LLC, Vanguard Group Inc., UBS Group AG, Vanguard Capital Management LLC